Hee C. Yoo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Advances in Engineered Virus-Like Particles for Genome Editing and Therapy.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: February 02, 2026
Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var.
Journal: Nature communications
Published: June 03, 2025
Strategies to overcome chemoresistance in epithelial ovarian cancer: Navigating beyond challenges.
Journal: Critical reviews in oncology/hematology
Published: September 19, 2024
Author Correction: O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine.
Journal: Nature communications
Published: October 21, 2022
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer.
Journal: Cancer research
Published: June 23, 2022
O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine.
Journal: Nature communications
Published: December 16, 2021
Structure-based modification of pyrazolone derivatives to inhibit mTORC1 by targeting the leucyl-tRNA synthetase-RagD interaction.
Journal: Bioorganic chemistry
Published: December 17, 2020
Glutamine reliance in cell metabolism.
Journal: Experimental & molecular medicine
Published: May 07, 2020
Last Updated: 09/26/2026